Announcements
26 May 2026
Interview with Dr. Sharun Khan—Winner of the Bioengineering Travel Award
Sharun Khan, MVSc, PhD, is a veterinarian and Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellow in the Regenerative Medicine Group, Department of Health Science and Technology, Aalborg University, Denmark. His current research focuses on tissue engineering and regenerative medicine (TERM), with particular emphasis on developing cell-based and cell-free therapeutic strategies to promote the regeneration of bone, cartilage, and skin. By integrating principles of materials science, tissue engineering, and regenerative medicine, Khan’s work bridges the gap between experimental findings and clinical applications, advancing the next generation of regenerative therapies.
1. First of all, congratulations on winning the Bioengineering Travel Award. Could you please tell us about your current research interests?
Thank you so much for your support and for this recognition. My current research is focused on developing smart biomaterials for bone tissue engineering and regenerative medicine. At the moment, I am working on a project called “BONEGEL: Development of a Novel BONE-Adapting Injectable Smart HydroGEL for Bone Tissue Engineering,” which is funded through the European Union’s Horizon Europe programme under a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. The idea behind the project came from a very practical clinical challenge. Bone defects, such as bone cysts, can seriously weaken the bone and increase the risk of fractures, but the currently available treatments often do not adapt well to the constantly changing environment of healing bone. Through BONEGEL, we are developing a material that can better communicate and adapt with the body during the regeneration process. What makes the project particularly exciting is that the hydrogel is injectable and self-healing, meaning it can fill irregular bone defects with minimal surgical intervention while maintaining its functionality. We use a dextran-based system that relies on host–guest interactions between cyclodextrin and adamantane, which gives the material its dynamic and adaptable nature. We are also incorporating nanosilicate to improve both the mechanical strength and the bone-forming potential of the hydrogel, along with a controlled release of dexamethasone to further support bone regeneration. More broadly, my research interests revolve around biomaterials, tissue engineering, and translational regenerative medicine. I am particularly interested in designing materials that are not only scientifically innovative but also clinically relevant and capable of improving patient outcomes in orthopaedic applications.
2. How did you hear about this award and how supportive might this kind of award be for researchers?
I have been aware of these travel awards since my PhD, as MDPI regularly supports early career researchers through Travel Awards and Young Investigator Awards offered by many of its flagship journals. Since these awards are announced each year cyclically, it is relatively easy for researchers to follow the application timelines and opportunities. Travel awards play a crucial role in enabling early-career researchers to participate in prestigious international conferences and symposia. With limited access to discretionary research and travel funding, the costs associated with conference registration, travel, and accommodation can be substantial, particularly for international meetings. Such awards, therefore, provide meaningful financial support that enables young researchers to present their work, engage with the scientific community, and establish collaborations that might otherwise be impossible. Beyond the financial aspect, I believe the greatest benefit of receiving the Bioengineering Travel Award is the professional visibility it provides to junior scientists. As the Bioengineering journal serves as an important platform for advances in bioengineering science and technology, recognition through this award enhances a researcher’s visibility within the global biomaterials and bioengineering community. This kind of acknowledgement can open doors to new collaborations, networking opportunities, and future career development. In addition, several MDPI awards offer APC waivers for early-career researchers, further supporting the dissemination of their research findings.
3. Could you briefly describe the conferences you plan to attend through the funding provided as part of this award, and discuss the significance of participating in such conferences for your research?
The MDPI Bioengineering Travel Award will support my participation in the 35th Annual Conference of the European Society of Biomaterials (ESB), scheduled to take place from September 7 to 11, 2026, in Antwerp, Belgium. I will present findings from my current MSCA-funded BONEGEL project, which focuses on developing an injectable, adaptive hydrogel system for bone tissue engineering. This conference is one of the most influential international platforms in biomaterials and bioengineering, and my participation will be instrumental in disseminating my current research project, receiving expert feedback, and advancing my professional development as a junior scientist. The ESB Annual Conference typically attracts over 1,000 participants from academia, clinical research, and industry, and the 2026 meeting is expected to host an even larger audience, as it coincides with the ESB’s 50th anniversary. This milestone event will bring together leading international experts, emerging researchers, and key stakeholders across the biomaterial community, thereby offering exceptional visibility and impact for presented research. Attending conferences such as ESB is also essential for building international collaborations and professional networks. As a postdoctoral researcher, these interactions play a major role in shaping future multidisciplinary projects and career opportunities. In addition, presenting my work at such a prestigious conference will increase the visibility of the BONEGEL project and contribute to broader discussions on the development of clinically relevant biomaterials for bone regeneration.
4. Do you have any suggestions for how our journal could further support young researchers and the academic community?
Yes, I think there are several ways the journal could further support young researchers and the wider academic community. One important aspect is visibility. Early career researchers often produce solid and innovative work, but it is not always easy for them to stand out. It would be very helpful if the journal could create more space to highlight young scientists, for example, through short researcher spotlights or accompanying features that introduce the people behind the work. This helps build recognition and also makes the research feel more connected to the community. I also think creating more opportunities for interaction beyond traditional publication would be very beneficial. For example, virtual webinars, thematic discussion sessions, or Early Career Editorial Boards where young researchers can contribute to shaping Special Issues. These initiatives will help build a sense of community rather than just a publication platform. It would be very valuable if the journal considered introducing a Young Investigator Award, similar to what MDPI already offers for some of its other journals. This initiative would be a strong way to recognize and motivate early career researchers, particularly within the bioengineering community, and would further encourage high-quality contributions from young scientists. The journal is already doing an important job of advancing the field, and these initiatives could further strengthen its role in supporting and shaping the next generation of researchers.
5. Could you share some advice for early career researchers who hope to make an impact in the field of bioengineering?
For early career researchers entering bioengineering, the most important thing is to stay curious and open to exploring questions that do not yet have clear answers. It is a very interdisciplinary field, so being willing to learn from areas like materials science, biology, and clinical medicine can really help shape research that is both meaningful and impactful. In my own case, I come from a veterinary background and now work in biomaterials research, so I have firsthand experience of how valuable it is to bridge different disciplines. That perspective has helped me better understand biological systems and also think more critically about how materials interact with living tissue in a clinically relevant way. At the same time, it is important to build a strong foundation in your own area of expertise. Early on, there can be pressure to move quickly across topics, but depth is just as important as breadth. Having a solid grounding in your core field gives you the confidence to develop original ideas rather than only following existing directions.
Communication is another aspect that I think is often underestimated. Being able to clearly explain your work to both specialists and non-specialists is essential. Whether it is writing a paper, presenting at a conference, or discussing your research informally, good communication often determines how your work is understood and valued. Resilience is also key. Research rarely moves in a straight line, and setbacks are part of the process. Learning to see failed experiments or unexpected results as part of scientific progress rather than as failures helps you grow as a researcher. I would also encourage early career researchers to actively seek collaborations and not work in isolation. Some of the most interesting ideas come from interdisciplinary discussions and different perspectives. Building a strong network early on can open unexpected opportunities and often shape the direction of your research in meaningful ways.
One area that will definitely continue to grow is smart and adaptive biomaterials. There is already a lot of interest in materials that can respond to the biological environment, release therapeutics in a controlled manner, and actively support tissue regeneration. I think this will become even more important in challenging areas such as cartilage regeneration, where current clinical solutions remain limited. Another direction is advanced tissue engineering, especially approaches that try to better mimic the natural complexity of tissues. This includes more sophisticated scaffold designs, bioprinting, and dynamic systems that can evolve over time as healing progresses. The goal is shifting from simply filling defects to actually guiding functional tissue regeneration.
Traditionally, animal models have been a major pillar of bioengineering research, especially for evaluating biomaterials and regenerative strategies. However, there is now a clear movement toward developing and validating alternative models that can better mimic human biology while also addressing ethical considerations and improving reproducibility. This includes advanced in vitro systems such as organoids, organ-on-a-chip platforms, and sophisticated 3D cell culture models. I also see a strong future for more personalized approaches in regenerative medicine. As we better understand patient variability, there will be greater emphasis on designing treatments that are tailored rather than one-size-fits-all. The integration of computational tools and biological data will likely play a big role here. At the same time, there will be a stronger focus on translational aspects, such as scalability, manufacturability, and regulatory pathways. These are often the bottlenecks between a good idea in the lab and something that can actually be used in the clinic, so they are becoming increasingly important in research planning.
20 May 2026
Meet Us at the 10th World Congress of Biomechanics 2026, 11–15 July, Vancouver, BC, Canada
15 May 2026
Meet Us at the 2026 International Workshop on Medical Ultrasound Tomography (MUST 2026), 12–14 June 2026, Wuhan, China
6 May 2026
MDPI INSIGHTS: The CEO's Letter #34 - MDPI US Office, Coatings 2026, Media and Partnerships, Recapping Poland Summit & Serbia Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Opens First US Office in Philadelphia
I am delighted to highlight an important milestone in MDPI’s continued global development: the recent opening of our first office in the United States, located in Philadelphia.
This marks a significant step in building our engagement with one of the world’s most important research communities. The new office will serve as a hub for supporting scholars across the US, creating closer connections and more localized support.
As highlighted in recent coverage by our press release in InPublishing, this expansion reflects MDPI’s broader commitment to growing our international presence while remaining focused on the needs of the research community.
A Key Market for Research and Collaboration
The United States continues to play a central role in global research. To date, MDPI has published more than 237,000 articles affiliated with US institutions, and we collaborate with nearly 12,000 Editorial Board Members across the country. These relationships are fundamental to our mission of supporting Open Access and advancing scientific communication.
The opening of this office is not just about geography; it is about proximity to the communities we serve. It allows us to better understand the evolving needs of researchers while continuing to build collaboration and trust within the academic ecosystem.
The Team Behind this Milestone
This milestone reflects the efforts of teams across MDPI. I extend a special thank-you to Bob Vrooman (Head of Business Development, MDPI), who is leading this expansion, as well as to our colleagues in Toronto and across our North American teams for their continued support.
Bob shared: “MDPI is already a trusted partner of the North American research community, due in no small part to our dedicated team in Canada. Launching our first US office in Philadelphia is a great first step towards expanding MDPI’s market share and recognition in the US. I’m thrilled to be a part of this new phase in MDPI’s journey.”
As we continue to grow, our focus remains on supporting researchers globally and advancing Open Access with integrity.
Impactful Research
Coatings 2026: Highlights from Our Latest MDPI Conference (20-22 April)
I am pleased to share the successful completion of MDPI conference Coatings 2026, which took place last week in Athens from 20 to 22 April 2026. This conference brought together a diverse international community of researchers, industry experts, and partners, highlighting MDPI’s role not only as a publisher but also as a platform for scientific exchange and collaboration.
Conference Highlights
Coatings 2026 in numbers:
- The event attracted approximately 140 participants from 25 countries
- 143 submissions and a strong scientific program of talks and posters
- 2 keynote speakers and a wide range of invited contributions
- 7 sponsors and 11 media partners supporting the event
|
|
|
|
|
|
Scientific Programme
The program centered on “Safe and Sustainable by Design,” reflecting the growing importance of sustainability, regulatory frameworks, and technological innovation in materials science. Topics ranged from advanced coating technologies and additive manufacturing to AI-driven simulations and strategies to phase out potentially harmful substances in industrial processes.
Importantly, the conference brought together both academic and industrial perspectives, creating a space for dialogue on how research can translate into real-world impact. This is important as industries navigate environmental challenges, evolving regulations, and the need for more sustainable and circular approaches to production.
Thank You!
I would like to thank the entire conference team for their work in organizing this successful event. As we continue to grow, conferences like this play an important role in building our connection with global research communities, supporting interdisciplinary collaboration, and positioning MDPI at the intersection of science, technology, and societal impact.
Members from Exelisis and MDPI EU Conference & Social Media team at the Coatings 2026 Conference in Athens, Greece.
Inside MDPI
Recent Media Coverage and Partnerships
Over the past two months, news from MDPI has enjoyed strong visibility across international publishing and academic media, reflecting our continued expansion and the increasing relevance of our work within the research community.
Below are some highlights covering partnerships, institutional agreements, and milestones that continue to shape our position in publishing – some of which are featured in leading industry platforms such as InPublishing, which is highly selective and reflects the growing recognition of MDPI’s growth within the publishing ecosystem.
Key Press Releases & Coverage (March–April 2026)
-
MDPI × Sikt (Norway): Partnership Renewal
We renewed our national Open Access agreement with Sikt, a key consortium partnership, continuing to support researchers across Norway through this partnership. The renewal was covered by several international publishing trade outlets.
Covered by: Research Information, STM Publishing News, ALPSP, Europe Says
-
MDPI × Jisc (UK): New Two-Year Open Access Agreement
A new two-year agreement with Jisc significantly expands MDPI’s footprint across UK academic institutions. Coverage appeared across major publishing industry titles in the UK and internationally.
Covered by: InPublishing, Research Information, STM Publishing News, ALPSP
-
MDPI Opens First US Office
The opening of our first US office marks an important milestone in our North American expansion to build engagement with one of the world’s leading research communities.
Coverage by: EurekAlert!, InPublishing, EdTech Innovation Hub, STM Publishing News, ALPSP
-
MDPI × SIGG: Italian Society of Gerontology and Geriatrics
We established a new partnership with the Italian Society of Gerontology and Geriatrics (SIGG), adding to our growing portfolio of society collaborations.
Coverage by: EurekAlert!, STM Publishing News, ALPSP
-
MDPI × Fast Track Health: New Journal Launch
The launch of a new journal in partnership with Fast Track Health reflects our continued expansion into emerging areas of health innovation.
Coverage by: EurekAlert!, Scienmag, STM Publishing News, ALPSP
-
MDPI 2025 Annual Report
Our 2025 Annual Report was also widely covered across international media, highlighting a 12% increase in submissions and continued investment in research integrity, infrastructure, and partnerships.
Coverage by: EurekAlert!, Research Information, STM Publishing News, ALPSP, Choice 360
Coverage also spanned multiple regions including Poland, Romania and South Korea, reflecting our ongoing efforts to communicate more effectively with regional research communities.
Looking Ahead
This coverage shows that MDPI is growing and building on its position through partnerships, visibility, and engagement across regions. As we continue to expand, our focus remains on supporting researchers globally, building on our institutional collaborations, and advancing Open Access with integrity.
Thank you to all teams involved in delivering these initiatives, and to our External Affairs team for ensuring our work is effectively communicated across the global publishing landscape!
Coming Together for Science
Recapping MDPI Poland Summit 2026 in Krakow (23 April)
On 23 April 2206, we hosted the first MDPI Poland Summit 2026 in Kraków, bringing together an engaged group of editors, researchers, and academic leaders from the country.
The Poland Summit welcomed some 45 participants, including Editors-in-Chief, Associate Editors, and Editorial Board Members, many with strong academic track records and international recognition.
Our engagements were open and constructive, focusing on MDPI’s positioning and reputation in Poland, alongside community interest in supporting our development, with active participation across our sessions, including Q&A and panel discussions.
|
|
|
|
MDPI Poland Summit Programme
From research integrity and peer review quality to AI in publishing and the future of academic communication, the agenda featured important topics currently shaping our industry.
During the day, MDPI colleagues shared a series of presentations covering:
- MDPI’s performance, growth, and impact in Poland: Stefan Tochev (CEO)
- Engagement with Academic Community: Dr. Marta Colomer (Public Affairs Lead)
- Research Integrity and Publication Ethics: Anna Pena (Research Integrity Manager)
- MDPI Editorial Process and Peer-Review Quality Metrics: Dr. Liliane Auwerter (Conference Organizer)
- AI in the Publishing Industry – Challenges, Innovation and MDPI’s vision: Dr. Enric Sayas (AI Product Owner)
- Panel Session: The Future of Academic Publishing, moderated by Dr. Marta Colomer
|
|
|
|
|
|
|
|
Poland as a Key Market for Open Access
The summit also highlighted the importance of Poland within the global research landscape.
In 2025:
- 75% of publications in Poland were made in Open Access
- 71% of those in Gold Open Access
- and over 344,000 publications produced in the last five years
MDPI plays a significant role in the Polish publishing ecosystem:
- #1 Open Access publisher in Poland
- 17% share of Open Access publications in 2025
- More than 12,500 publications from Polish institutions in 2025
- More than 91,000 publications overall since 1996
Looking Ahead
Events like the Poland Summit are an important part of how we evolve as an organization. They allow us to share the latest developments of MDPI and listen directly to our researchers and editors to better understand the market and align our development with the needs of the local community.
As MDPI continues to grow, this type of engagement will remain essential in ensuring that we are not only scaling globally, but doing so in a way that is aligned, trusted, and collaborative.
With Igor Matic (Office Manager, Krakow, Poland, MDPI) at the MDPI Poland Summit in Krakow.
Closing Thoughts
Recapping MDPI Serbia Salon 2026 in Belgrade (22 April)
On 22 April 2026, we hosted the MDPI Serbia Salon 2026 in Belgrade. The Salon welcomed over 50 participants, including more than 40 invited scholars from leading Serbian institutions, alongside colleagues from MDPI. The event also marked two important milestones: 30 years of MDPI and 10 years of our presence in Serbia, making it a celebration and an opportunity for reflection.
A Platform for Exchange
The Salon was designed not just as a series of presentations, but as a place for dialogue. Throughout the day, discussions focused on important topics around publishing today: research integrity and editorial standards, journal indexing and visibility, the evolving role of artificial intelligence, and funding and support for Open Access publishing.
|
|
|
|
|
|
|
|
Program Overview
- Opening the Salon MDPI Serbia 2026 – Serbia results and direction: Emir Ramadani (Operations Manager)
- Update on MDPI’s performance and growth: Stefan Tochev (CEO)
- Collaboration with MDPI – A personal perspective: Prof. Dr Srećko Stopić (Editorial Board Member)
- Linking Scientific Quality and Visibility: The role of indexing in publishing
- Research integrity and editorial ethics: Ana Stanković (Research Integrity Specialist)
- Artificial Intelligence in Scientific Publishing – Challenges, innovations and vision of MDPI: Dr Miloš Čučulović (Head of Technology Innovation)
It was encouraging to see the high level of engagement and discussion with the local academic community.
|
|
|
|
|
|
|
|
Publishing in Serbia
With 10 years of MDPI in Serbia (since 2016) and over 620 colleagues across 10 departments spread across offices in Belgrade and Novi Sad, MDPI continues to invest in the long-term development of the research community in Serbia and beyond.
Some high-level indicators illustrate both the strength of the local research ecosystem and MDPI’s role within it:
- 12,910 total publications in Serbia in 2025, of which 8,708 (67%) were Open Access (of which, in turn, 75% were Gold OA)
- A total of more than 55,000 publications (2021–2025), with 68% published Open Access
- 2,122 MDPI publications from Serbian institutions in 2025
- 25% of all Open Access publications in Serbia are published with MDPI
- More than 11,000 MDPI publications from Serbian institutions since 1996
- More than 75 Editorial Board Members from Serbia, including Editors-in-Chief and Associate Editors.
These figures reflect the growth of OA publishing in Serbia and the strong collaboration between MDPI and Serbia's research community.
Top 5 Publishers in Serbia (MDPI #1 with steady growth)
Looking Ahead
Research integrity and artificial intelligence will remain central topics for the industry. At the same time, clear communication of editorial processes will be essential in building trust and transparency.
Workshops and direct engagement remain among the most effective ways to strengthen these connections. As Open Access funding models continue to evolve, new opportunities for collaboration are emerging across institutions, publishers, and the broader research community.
Thank You!
The excellent feedback from participants shows the value of creating spaces where ideas can be exchanged openly and constructively. Sincere thanks to everyone who contributed to the success of this event: our speakers, participants, and especially the MDPI Serbia team for their great organization and support.
Chief Executive Officer
MDPI AG
24 April 2026
Prof. Dr. William Gerwick Appointed Chair of the 2026 Tu Youyou Award Committee
We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.
A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.
Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.
To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.
A Conversation with the Chair
1. Could you please introduce yourself and your research journey?
My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.
I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.
Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.
2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?
Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.
3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?
A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.
4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?
Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.
5. What do you see as the key challenges or opportunities currently facing the field?
We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.
6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?
The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.
7. What message would you like to convey to the research community and the public during this open nomination phase?
This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.
The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
20 April 2026
Meet Us at the 2026 China Biomedical Engineering Conference & Medical Innovation Summit (BME), 29–31 May 2026, Suzhou, China
16 April 2026
MDPI’s Newly Launched Journals in the First Quarter of 2026
Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.
We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Matt Oehlschlaeger, |
AI-based chemical data analysis, prediction, and discovery; AI-enabled chemical reaction prediction, synthesis planning, and retrosynthesis; AI in bioorganic chemistry and chemical biology; digital twins and simulation of chemical processes; AI-powered chemical education and pedagogy | |
|
|
Prof. Dr. Guang Jia, |
occupational hazards and exposure science; occupational health effects and susceptibility; occupational risk assessment and management; occupational health intervention, promotion, and policy | |
|
|
Prof. Dr. Alessandro Miani, |
environmental exposures and health; the built environment and public health; One Health approach; environmental justice and health equity; environmental policies and interventions | |
|
|
Prof. Dr. Miriam H. A. Bopp, |
neuroimaging technology and tool; multimodal neuroimaging integration and analysis; |
|
|
Prof. Dr. Raul A. Urrutia, |
personalized translational and clinical oncology research that contribute to a deeper understanding of cancer diagnoses, prognoses, prevention, and treatment specifically for individual patients | |
|
|
Prof. Dr. Pierre Boulanger, |
AI in disease detection, diagnosis, prediction, and treatment; medical informatics; AI in genomics and precision medicine; AI in drug discovery and development; |
|
|
Prof. Dr. Zhaokui Wang, |
astrodynamics; spacecraft technology; satellite technology; space transportation; space vehicle design, propulsion, and avionics; space energy, power and propulsion | |
|
|
Prof. Dr. Richard J Hauer, |
park design, planning, and evaluation; park and art; park, industrialization, urbanization, and civilization; park and education; park and smart society; park role in SDGs; park services for humans | |
|
|
Prof. Dr. Stacey L. Connaughton, |
conflict resolution; peacebuilding; peacemaking; mediation, reconciliation, and transitional justice; sustaining peace | |
|
Transferred Journals |
Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Gianluigi Vendemiale, |
physiology and pathology of aging; biogerontology; epidemiology; clinical geriatrics; pharmacology; geriatric nursing | |
|
|
Prof. Dr. Michele Maffia, |
cellular and developmental biology; physiology, pathophysiology and endocrinology; diagnostic tools, therapies and public health | |
|
|
Dr. Warren S. Joseph, |
foot and ankle medicine; podiatric medicine | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).
2 April 2026
2026 Tu Youyou Award—Open for Nominations
1 April 2026
Meet Us at the 9th China–Europe Symposium on Biomaterials in Regenerative Medicine in 2026, 10–13 May 2026, Beijing, China
31 March 2026
MDPI INSIGHTS: The CEO’s Letter #33 - 2025 Annual Report, Preprints.org, IWD, Recapping Viruses 2026 & Romania Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Scaling Open Access with Integrity: MDPI Annual Report 2025
I am pleased to share the release of MDPI’s 2025 Annual Report, reflecting our continued progress as one of the world’s leading open access publishers. The report highlights not only our growth, but also the continued evolution of our publishing model and our commitment to quality, transparency, and collaboration.
You can explore the full report here: https://mdpi-res.com/data/mdpi_annual_report_2025_0401.pdf?1775045421
Or visit the interactive page: https://www.mdpi.com/annual-report-2025/
A Year of Growth and Responsibility
2025 was a year of significant growth for MDPI. We received over 669,000 manuscript submissions, the highest in our history, while maintaining a rejection rate above 60%, reinforcing our commitment to both scale and quality.
We published 261,576 peer-reviewed open access articles across a portfolio of 500 journals, supported by a global community of more than 68,000 Editorial Board Members and 209,000 reviewers.
Scaling with Integrity
Growth alone is not the objective; how we grow matters.
Our 2025 Annual Report, Scaling Open Access with Integrity, reflects our continued focus on building the systems and processes that support reliable and trustworthy publishing. As submission volumes increase globally, so too does the importance of robust editorial workflows, research integrity frameworks, and the infrastructure required to support them.
In 2025, we continued to invest in:
- Research integrity and quality assurance processes
- Editorial support and reviewer engagement
- Transparency across the publishing workflow
These efforts ensure that scale does not come at the expense of rigor, but rather reinforces it.
Validation Through Indexing and Visibility
As MDPI continues to grow, validation of quality remains essential.
In 2025, the number of MDPI journals indexed in the Web of Science Core Collection increased from 298 to 329, while Scopus coverage reached 355 journals, including 45 new acceptances. Coverage in major biomedical databases (PMC/Medline/PubMed) expanded to 95 journals, and indexing in Ei Compendex increased significantly.
These milestones reflect the strength of our editorial processes and the trust placed in our journals by independent indexing bodies.
Importantly:
- 96% of all MDPI articles are indexed in Web of Science databases
- More than 1.75 million articles are indexed, with an average of 13 citations per article
Recognition through Journal Citation Reports also continues to grow:
- 298 journals received Impact Factors
- 65% ranked in the top half of their categories
- 61 journals achieved top-quartile positions
These developments demonstrate that growth and quality are advancing together, supported by strong editorial oversight and consistent performance across our journal portfolio.
Strengthening Partnerships and Community
Open access is a collaborative endeavor.
In 2025, we expanded our institutional partnerships to more than 1,000 IOAP agreements, helping simplify publishing for researchers and institutions worldwide.
We also hosted 60 in-person conferences and virtual events, bringing together more than 28,000 participants to exchange ideas, share research, and strengthen connections across the global scientific community.
At the heart of everything we do is this community of authors, editors, reviewers, and partners who make open science possible.
Looking Ahead
Open access continues to move toward becoming the standard model for sharing research globally. With that growth comes increased responsibility.
Our focus moving forward is to continue building a publishing ecosystem that is:
- Collaborative, to serve the research community
- Rigorous, to ensure quality
- Transparent, to support trust
- Scalable, to meet global demand
We believe that open access, when combined with strong editorial standards and integrity, is the most effective way to accelerate scientific progress.
Thank you to all the scholarly community who collaborated with us and our MDPI staff for your continued dedication and contributions in making 2025 a successful year.
Impactful Research
Celebrating Ten Years of Preprints.org: Accelerating Open Research
In 2026, MDPI’s preprints server Preprints.org marked its 10th anniversary as a platform dedicated to accelerating the dissemination of research. Since its launch, Preprints.org has grown into a global platform that hosts more than 120,000 preprints contributed by hundreds of thousands of researchers worldwide, generating tens of millions of views and downloads and demonstrating the value of sharing research openly and rapidly.
At MDPI, we are proud to celebrate ten years of Preprints.org supporting the mission of open science. Over the past decade, we have seen how early sharing of research can accelerate collaboration and help ideas move more quickly from discovery to impact.
The Evolution of Preprints
While Preprints.org launched in 2016, the idea behind it has deeper roots. The concept of rapid research dissemination has existed for decades, with early preprint servers showing how open sharing can accelerate scientific progress.
Over the past decade, preprints have become an increasingly important part of scholarly communication. Researchers across disciplines are looking at faster ways to share their discoveries, exchange ideas, and receive feedback from the global scientific community.
Preprints in a Growing Research Ecosystem
The global preprint landscape has expanded significantly over the past decade, with multiple platforms serving different research communities. The figure below (sourced from James Butcher newsletter), based on data from Dimensions (Digital Science), shows the growth of preprint outputs across several major platforms over time.
Among these platforms, arXiv (the pioneering preprint server) has experienced great growth in recent years. At the same time, other platforms have continued to expand their reach across disciplines, capturing increasing global interest in early research sharing.
Preprints.org contributes to this evolving ecosystem by providing a multidisciplinary platform that works in synergy with academic journals, helping researchers bridge the gap between rapid dissemination and the formal publication process.
Celebrating the First Decade
To commemorate this milestone, Preprints.org launched a 10th Anniversary celebration hub highlighting the impact of preprints and the researchers who contribute to them.
One of the central initiatives is the Popular Preprints of the Decade Award, recognizing influential preprints published between 2016 and 2026 across multiple research fields. Through community voting, the award will recognize research that has generated high engagement and visibility within the global research community.
Looking Ahead: The Next Decade of Preprints
As research communication continues to evolve, preprints will continue to play an important role in enabling faster collaboration, improving transparency, and expanding access to knowledge. The next decade may bring further integration between preprint platforms and journals, new tools for discovery and evaluation, and greater global participation in open science.
At MDPI, we remain committed to supporting researchers through platforms that encourage the open exchange of ideas. The success of Preprints.org over the past ten years reflects the engagement and trust of the global research community – authors, readers, reviewers, and collaborators who believe in the value of sharing knowledge openly.
Congratulations to everyone involved in the development and growth of Preprints.org over the past decade!
Inside MDPI
Beyond International Women’s Day: Supporting Women in Research
International Women’s Day (IWD) offers an opportunity to recognize the achievements of women around the world and reflect on how we can continue building a more inclusive future. In research and academia, this conversation carries particular importance, as scientific progress depends on diverse perspectives, and supporting women in science is essential to strengthening the global research ecosystem.
For MDPI, IWD is an opportunity to celebrate the achievements of women in research and highlight the initiatives, conversations, and collaborations that help support researchers across disciplines and career stages.
Highlighting Women in Science Across MDPI
This year, MDPI marked International Women’s Day with a global campaign highlighting research, awards, and perspectives that support women in science. Throughout the week, our teams shared content across MDPI’s social media channels sharing the work of women researchers and encouraging engagement across the academic community.
As part of this initiative, MDPI published several blog articles exploring important themes related to gender equity in research. One article, Give Support, Gain Progress: Retaining Women in Science, discusses the importance of mentorship, institutional support, and inclusive research environments in helping women build sustainable scientific careers.
Another featured article, Bridging the Gap in Women’s Health Research, highlights the ongoing need to address disparities in health research and ensure that women’s health receives the scientific attention and investment it deserves.
These topics capture the notion that supporting women in science benefits not only individual researchers but the entire scientific community. When researchers from diverse backgrounds can contribute their perspectives and ideas, the scope and impact of scientific discovery expand.
Creating Spaces for Dialogue
Beyond online content, MDPI is also supporting conversations about women in research through community engagement.
On 10 March, MDPI UK hosted the “Women in Research” event, bringing together researchers and professionals to share experiences and discuss the opportunities and challenges women face throughout their scientific careers. Events like these are an opportunity for open dialogue, mentorship, and networking to create more inclusive research communities.
Looking Beyond a Single Day
While IWD is an important moment of recognition, progress requires ongoing effort.
Supporting women in research involves many forms of engagement: from mentorship and collaboration to creating inclusive environments in which diverse voices are heard and valued. Publishers, institutions, and researchers all play a role in building this ecosystem.
At MDPI, we remain committed to supporting the global research community and to promoting open access publishing as a foundation for accessible and inclusive knowledge-sharing.
As we reflect on IWD this year, we recognize the many women who contribute to research as authors, reviewers, editors, mentors, and educators; we also recognize the impact they continue to have on the advancement of science. The influence of women in research extends far beyond a single day of recognition, reminding us that supporting them is a commitment that continues throughout the year.
Coming Together for Science
Highlights from Viruses 2026 – New Horizons in Virology (11–13 March)
Through 11–13 March, we successfully delivered the Viruses 2026 – New Horizons in Virology MDPI conference in Barcelona, bringing together an international community of researchers, editors, and partners dedicated to advancing the field of virology.
Conference Highlights
Viruses 2026 in numbers:
- 198 total registrations, with 171 attendees on site
- 233 submissions, with 122 accepted
- 42 short talks, 9 flash talks, and 80 posters
- 13 invited speakers and 1 keynote speaker
The strong level of participation and quality of submissions once again demonstrate the relevance of the Viruses community.
A standout moment was the keynote lecture by Dr. Ho, which also attracted an NBC documentary film crew, highlighting the broader impact of the research being presented.
Scientific Programme
The conference programme covered areas across modern virology, including viral replication, pathogenesis, immunology, and public health. Sessions explored topics on antiviral therapeutics and vaccines, innate immunity, virus–host interactions, and the structure and mechanisms of virus replication.
Together, these discussions highlighted both the fundamental biology of viruses and the translational challenges of addressing emerging infectious diseases, reflecting the breadth and continued importance of virology research in a global context. The programme also included a sponsored workshop on research data management in virology, further emphasizing the importance of data practices in advancing the field.
Thank You
Feedback from participants has been very positive, and I would like to thank the Conference team for the organization and delivery of this year’s event.
Thank you to our Viruses journal team and all colleagues involved behind the scenes in supporting the delivery of the event. As noted by Dr. Eric Freed (EiC of Viruses), the success of this edition gives us strong momentum as we look ahead to the next conference in 2028, with opportunities to further expand participation and engagement.
Closing Thoughts
Recap from MDPI Romania Salon in Cluj-Napoca (24 March)
On 24 March, we had the opportunity to meet with members of the Romanian research community in Cluj-Napoca at our MDPI Romania Salon. The event was a space for presentations, open discussion, and the exchange of perspectives on publishing and the research landscape in Romania.
We welcomed 39 participants, including 27 researchers from institutions across Romania, representing cities such as Cluj-Napoca, Timișoara, and Reșița. Among them were Editorial Board Members, Associate Editors, and Guest Editors, all of whom play an important role in collaborating with MDPI and shaping the quality and direction of academic publishing.
|
|
|
|
A Shared Commitment to Research Excellence
These events reflect MDPI’s commitment to connecting with and supporting researchers by means of transparency, dialogue, and collaboration. During the day, MDPI colleagues shared a series of presentations covering different parts of our publishing ecosystem:
- MDPI’s presence in Romania – Anamaria Vartolomei (Journal Relationship Specialist (JRS), Section Managing Editor (ME))
- MDPI’s performance, growth, and impact in Romania – Stefan Tochev (CEO)
- Academic services, initiatives, and projects supporting researchers – Ioana Preda (JRS, Section ME)
- Best practices and standards in publication ethics – Lavinia Rogojina (Research Integrity Manager)
- Panel session on ethics, AI, and peer review – Lavinia Rogojina, Ioana Preda, Doris Larisa Albu (JRS, Section ME), Cristina Georgiana Spelmezan (JRS, Section ME)
- Closing remarks – Lavinia Dumitrela Cozma (Operations Manager, Section ME)
Feedback from participants was very positive, particularly regarding the quality of discussions, the relevance of the topics, and the opportunity to engage directly with MDPI colleagues. What stood out most was the openness of the discussion. These events are important not only for the purposes of presenting what we do, but also as an opportunity to listen, understand concerns, and continue to build alignment with the research community.
Romania and the Growth of Open Access Publishing
The Romanian research landscape continues to show growth in open access (OA) publishing.
In 2025:
- 72% of all publications in Romania were published as OA
- Of these, 74% were Gold Open Access
Over the past five years, Romania has produced more than 109,000 publications, with approximately 71% available openly, highlighting a sustained shift toward accessibility and knowledge-sharing.
Within this landscape, MDPI continues to play a significant role:
- MDPI is the leading OA publisher in Romania, contributing 42% of all OA publications in 2025
- More than 37,000 articles have been published with MDPI by Romanian institutions since 1996
- This figure includes over 7,500 publications in 2025 alone
- More than 400 Editorial Board Members from Romania collaborate with MDPI across disciplines
These trends show the growth of OA and the strength of collaboration between MDPI and the Romanian research community.
Looking Ahead
As academic publishing continues to evolve, maintaining open and transparent communication with researchers is essential. Events such as our Salons and Summits provide great opportunities to exchange perspectives and to build trust and collaboration.
Thank you to all participants who joined us in Cluj, and to our teams in Romania for delivering a successful event. A special thank-you to Alina-Florina Agafitei (Marketing Specialist) for her care and attention to detail in delivering the Salon.
Chief Executive Officer
MDPI AG
